Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Meng XU"'
Publikováno v:
Translational Cancer Research. 11:1819-1823
Autor:
Feng Ma, Xinhai Zhu, Yuchun Niu, Aitao Nai, Shoaib Bashir, Yan Xiong, Yunlong Dong, Yin Li, Jian Song, Meng Xu
Publikováno v:
Frontiers in Oncology. 13
Lung cancer has high morbidity and mortality rates worldwide, and NSCLC accounts for 85% of all lung cancer cases. Despite the development of targeted therapies and immunotherapy, many NSCLC patients do not effectively respond to treatment, and new t
Autor:
Jinghui Liu, Chen Li, Yuan Wang, Peigang Ji, Shaochun Guo, Yulong Zhai, Na Wang, Meng Xu, Julei Wang, Liang Wang
Publikováno v:
Frontiers in Oncology. 12
IntroductionSecondary gliosarcomas (SGS) are rare malignancies that are diagnosed subsequent to pre-existing glioma. Clinical features and optimal treatment strategies for SGS have not been conclusively established. This study aimed to assess the cli
Autor:
Laura Tonnetti, Roger Y Dodd, Donna D Burke, Paula Saá, Bryan R Spencer, Meng Xu, James M Haynes, Susan L Stramer
Publikováno v:
Open Forum Infectious Diseases. 10
Background Blood donors were tested for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); resulting antibody levels were monitored over time. Methods Donors reactive to anti-SARS-CoV-2 spike protein (S1-total antibodies) par
Publikováno v:
Oncology Reports. 49
Publikováno v:
Translational Cancer Research
Background The therapeutic strategies and prognosis of local advanced and metastatic lung cancer have been extensively investigated. However, the prognosis of early-stage lung cancer patients undergoing radical surgery has not been fully studied due
Publikováno v:
Journal of cancer research and therapeutics. 18(2)
Golgi phosphoprotein-3 (GOLPH 3) is involved in the development of several human cancers. However, the clinical significance and biological role of GOLPH 3 in ovarian cancer (OC) remains unknown.The expression of GOLPH 3 in OC cell lines was quantifi
Autor:
Auranuch Lorsakul, Andrea Muranyi, Uday Kurkure, Kien Nguyen, Wen-Wei Liu, Isaac Bai, Jennifer H. Barrett, Christoph Guetter, Kandavel Shanmugam, Matthew T. Seymour, Philip Quirke, Michael Barnes, Dongyao Yan, Jenny F. Seligmann, Susan D. Richman, Zuo Zhao, Nicholas P. West, Xiao-Meng Xu, Xingwei Wang, Liping Zhang, James R. Martin, Faye Elliott, Michael Shires, Christopher J.M. Williams, Sarah Brown, Judith Pugh, Shalini Singh
Publikováno v:
Clinical Cancer Research. 27:3422-3431
Purpose: High tumor mRNA levels of the EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are associated with anti-EGFR agent response in metastatic colorectal cancer (mCRC). However, ligand RNA assays have not been adopted into routine practice
Autor:
Ming Lu, Yongmeng Li, Renchang Zhao, Meng Xu-Welliver, Chuanle Cheng, Stéphane Renaud, Zitong Feng, Rui Dong, Hui Tian, Jingyi Han, Jinghui Liang, Jin Jiang
Publikováno v:
Transl Lung Cancer Res
Background Lung cancer is a malignant tumor with the highest morbidity and mortality rates worldwide, of which lung adenocarcinoma (LUAD) is the most common subtype. Overall, current treatments of LUAD are not satisfactory; therefore, novel targets n
Autor:
Yong Zhang, Zhuxin Wei, Kai Hu, Bo Li, Li Jiang, Jing-Lin Mi, Chun-Yu Lin, Meng Xu, Zhendong Yang, Fang Wu, Min Kang, Rensheng Wang
Publikováno v:
Cancer Science
The microRNAs (miRNAs) in circulating small extracellular vesicles (sEVs) have been suggested as potential biomarkers in cancer diagnosis. This study was designed to evaluate the circulating sEV‐derived miRNAs as biomarkers for the diagnosis of nas